Skip to main content

China’s Black Market Stem Cells

Despite government efforts to ban unapproved stem cell treatments, companies around China still offer them openly.

Written byMegan Scudellari
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA COMMONS, CALLE EKLUND/V-WOLF

In January, the Chinese Ministry of Health once again attempted to regulate the unapproved stem-cell tourism business in China, announcing rules such as required registration for organizations using stem cells in the clinic and a halt to any unapproved stem cell treatments. But not a single clinic has registered, and business is still booming, according to an investigation by Nature.

The clinics, which operate openly, offer expensive and unapproved stem cell treatments for Parkinson’s disease, diabetes, and autism, among other disorders, and attract thousands of medical tourists from around the world. The Chinese health ministry has made several attempts to ban the treatments, including classifying stem-cell treatments as “high risk” and requiring the approval of a technical audit board, but to no avail.

The clinics ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo